RDY · Dr Reddys Laboratories Ltd · Documents

$13.94 -0.21 (-1.48%) Q2 2026 earnings call transcript

Market Cap

$11.73B

833.07M

Volume · Oct 28 4.47M Avg daily vol (3M) 2.92M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	AI summary	Filing Date	Period
6-K	—	2022-04-01	—
6-K	—	2022-03-29	—
6-K	—	2022-03-17	—
6-K	—	2022-03-17	—
6-K	—	2022-02-28	—
6-K	—	2022-02-25	—
6-K	—	2022-02-25	—
6-K	—	2022-02-22	2022-02-21
6-K	—	2022-02-14	—
6-K	—	2022-02-11	—
6-K	—	2022-02-09	—
6-K	—	2022-02-09	—
6-K	—	2022-02-09	2022-02-08
6-K	—	2022-02-07	—
6-K	—	2022-02-03	—
6-K	—	2022-02-02	—
6-K	—	2022-02-01	—
6-K	—	2022-01-31	2022-01-30
6-K	—	2022-01-28	—
6-K	—	2022-01-28	2021-12-31
6-K	—	2022-01-28	—
6-K	—	2022-01-18	2022-01-17
6-K	—	2022-01-18	—
6-K	—	2022-01-10	—
6-K	—	2022-01-07	—
6-K	—	2021-12-28	—
6-K	—	2021-12-20	2021-12-18
6-K	—	2021-12-10	2021-12-09
6-K	—	2021-12-10	—
6-K	—	2021-12-09	—
6-K	—	2021-11-08	2021-11-06
6-K	—	2021-11-08	2021-11-05
6-K	—	2021-11-05	—
6-K	—	2021-11-01	2021-10-29
6-K	—	2021-11-01	2021-10-30
6-K	—	2021-10-29	—
6-K	—	2021-10-19	—
6-K	—	2021-10-18	2021-10-15
6-K	—	2021-10-15	2021-10-14
6-K	—	2021-10-07	—
6-K	—	2021-09-27	2021-09-24
6-K	—	2021-09-22	—
6-K	—	2021-09-10	2021-09-09
6-K	—	2021-09-07	2021-09-04
6-K	—	2021-09-07	—
6-K	—	2021-09-03	2021-09-02
6-K	—	2021-09-02	—
6-K	—	2021-08-31	—
6-K	—	2021-08-10	2021-08-09
6-K	—	2021-08-04	—

Showing 551–600 of 745 filings

Key facts CIK 1135951 CUSIP 256135203 13F (30d) 59 filings 54 filers Visit website Investor relations